Mental Health
Cost-effectiveness of depression treatments for underprivileged women analyzed
Published in Health and Medicine Week, October 10th, 2005
Researchers from the United States wrote, "Few clinical trials have evaluated interventions for major depressive disorder in samples of low-income minority women, and little is known about the cost-effectiveness of depression interventions for this population." They sought "To evaluate the cost-effectiveness of pharmacotherapy or cognitive behavior therapy (CBT) compared with community referral for major depression in low-income minority women."
D. A. Revicki and colleagues conducted "A randomized clinical trial in 267 women with current major...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Drug Development
Zomig proves effective in acute treatment of cluster headache - Environmental Health
Study identified diseases that correlate with suspended particle concentration - HIV/AIDS Epidemiology
Survey shows wealthy, educated women most vulnerable to HIV in Cameroon - Medical Devices
Trocar-associated injuries and fatalities examined - Obesity & Diabetes
Metabolic syndrome involves both diet and genetics - Acute Kidney Injury
Even minor kidney injury increases risk of death in the hospital - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
